A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells

Cell

Volumn 65, Issue 1, 1991, Pages 13-24

  Günthert, Ursula ^a   Hofmann, Martin ^b   Rudy, Wolfgang ^a   Reber, Sonja ^c   Zöller, Margot ^c   Haußmann, Irmgard ^a   Matzku, Siegfried ^c   Wenzel, Achim ^c   Ponta, Helmut ^b   Herrlich, Peter ^a,b  

^a UNIVERSITY OF KARLSRUHE   (Germany)

^b KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN;

ARTICLE; CARCINOMA CELL; METASTASIS POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN VARIANT; RAT;

AMINO ACID SEQUENCE; ANIMAL; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTIBODY SPECIFICITY; BASE SEQUENCE; CLONING, MOLECULAR; DNA, NEOPLASM; EPITOPES; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; RATS; RECEPTORS, LYMPHOCYTE HOMING; RESTRICTION MAPPING; RNA, MESSENGER; RNA, NEOPLASM; SEQUENCE HOMOLOGY, NUCLEIC ACID; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

MURINAE;

EID: 0025825209     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/0092-8674(91)90403-L     Document Type: Article

References (65)

1. CD44 is the principal cell surface receptor for hyaluronate
2. Transcription termination and 3′ processing: the end is in site!
3. H) oncogene in mediating progression of the tumor cell phenotype
4. Lymphatic metastasis of mammary adenocarcinoma: an experimental study in the rat with a brief review of the literature
5. Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells
6. Prediction of protein conformation
7. Invasive and metastatic potential induced by ras-transfection into mouse BW5147 T-lymphoma cells
8. Transcriptional down-regulation of a rat gene, WDNM2, in metastatic DMBA-8 cells
9. Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation
10. Expression of H-ras correlates with metastatic potential: evidence for direct regulation of the metastatic phenotype in 10T1/2 and NIH 3T3 cells
11. Adenovirus ElA represses protease gene expression and inhibits metastasis of human tumor cells
12. Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer
13. Structural homology between lymphocyte receptors for high endothelium and class III extracellular matrix receptor
14. Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1 a
15. Inhibition of in vitro tumor cell invasion by Arg-Gly-Aspcontaining synthetic peptides
16. A human lymphocyte homing receptor, the hermes antigen, is related to cartilage proteoglycan core and link proteins
17. A versatile in vivo and in vitro eukaryotic expression vector for protein engineering
18. A one tube reaction for the synthesis of blunt-ended double-stranded cDNA
19. Molecular aspects of the metastatic cascade
20. CD44—a molecule involved in leukocyte adherence and T-cell activation
21. CD44 contributes to T cell activation
22. Murine cell surface glycoproteins
23. A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells
24. Isolation and DNA sequence of a cDNA clone encoding a lymphocyte adhesion receptor for high endothelium
25. YIGSR, a synthetic laminin pentapeptide, inhibits experimental metastasis formation
26. Redistribution of a major cell surface glycoprotein during cell movement
27. Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85–95 kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells
28. A family of cell-surface glycoproteins defined by a putative anti-endothelial cell receptor antibody in man
29. Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells
30. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs
31. Cleavage of structural proteins during assembly of the head of bacteriophage T4
32. Binding of hyaluronic acid to lymphoid cell lines is inhibited by monoclonal antibodies against Pgp-1
33. Natural cytotoxicity in lymphatic metastasis. II. In vivo studies with BSp73 variants differing in metastatic capacity
34. Characterization of Bsp 73, a spontaneous rat tumor and its in vivo selected variants showing different metastasizing capacities
35. Antigenic differences between metastatic and nonmetastatic BSp73 rat tumor variants characterized by monoclonal antibodies
36. Metastasis inhibition of different tumor types by purified laminin fragments and a heparin-binding fragment of fibronectin
37. Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade
38. Harvey ras induction of metastatic potential depends upon oncogene activation and the type of recipient cell
39. Development and biologic properties of malignant cell sublines and clones of spontaneously metastasizing rat mammary adenocarcinoma
40. Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression
41. Isolation of mouse CD44 cDNA: structural features are distinct from the primate cDNA
42. Structural heterogeneity of human Pgp-1 and its relationship with p85
43. Plasminogen activator dependent pathways in the dissemination of human tumor cells in the chick embryo
44. Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types
45. The El a gene of adenovirus type 2 reduces the metastatic potential of ras-transformed rat embryo cells
46. Evidence for a precursor of the high-affinity metastasis-associated murine lam inin receptor
47. Identification of the metastasis-associated galactoside-binding lectin as a chimeric gene product with homology to an IgE-binding protein
48. Retardation of metastatic tumor growth after immunization with metastasis-specific monoclonal antibodies
49. Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells
50. Improved plasmid vectors with a thermoinducible expression and temperature-regulated runaway replication
51. DNA sequencing with chain-terminating inhibitors
52. Differential axon usage involving an unusual splicing mechanism generates at least eight types of WCAM cDNA in mouse brain
53. Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine 1316-F10 melanoma cells
54. A cellular oncogene (c-Ki-ras) is amplified, overexpressed, and located within karyotypic abnormalities in mouse adrenocortical tumour cells
55. Dual role of the CD44 molecule in T-cell adhesion and activation
56. Polypeptide variation in an WCAM extracellular immunoglobulin-like fold is developmentally regulated through alternative splicing
57. Alternative splicing in the control of gene expression
58. Expression of CD44 confers a new adhesive phenotype on transfected cells
59. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family
60. Construction of a new family of high efficiency bacterial expression vectors: identification of cDNA clones coding for human liver proteins
61. Evidence for a novel gene associated with low tumor metastatic potential
62. Monoclonal antibodies that prevent adhesion of B16 melanoma cells and reduce metastases in mice: crossreaction with human tumor cells
63. A new method for predicting signal sequence cleavage sites
64. cDNA cloning of a novel cell adhesion protein expressed in human squamous carcinoma cells
65. Molecular cloning and expression of Pgp-1: the mouse homolog of the human H-CAM (Hermes) lymphocyte homing receptor